(Q35097294)

6 August 2017

title

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). (English)

1 reference

multicenter clinical trial

6 August 2017

main subject

0 references

0 references

1 reference

2

Russell E Ware

1 reference

6 August 2017

Winfred C Wang

1

1 reference

6 August 2017

Scott T Miller

3

1 reference

6 August 2017

Rathi V Iyer

4

1 reference

6 August 2017

James F Casella

5

1 reference

6 August 2017

Caterina P Minniti

6

1 reference

6 August 2017

Sohail Rana

7

1 reference

6 August 2017

Courtney D Thornburg

8

1 reference

6 August 2017

Zora R Rogers

9

1 reference

6 August 2017

Ram V Kalpatthi

10

1 reference

6 August 2017

Julio C Barredo

11

1 reference

6 August 2017

R Clark Brown

12

1 reference

6 August 2017

Sharada A Sarnaik

13

1 reference

6 August 2017

Thomas H Howard

14

1 reference

6 August 2017

Lynn W Wynn

15

1 reference

6 August 2017

Abdullah Kutlar

16

1 reference

6 August 2017

F Daniel Armstrong

17

1 reference

6 August 2017

Beatrice A Files

18

1 reference

6 August 2017

Jonathan C Goldsmith

19

1 reference

6 August 2017

Myron A Waclawiw

20

1 reference

6 August 2017

Xiangke Huang

21

1 reference

6 August 2017

Bruce W Thompson

22

1 reference

6 August 2017

BABY HUG investigators

23

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

377

1 reference

6 August 2017

issue

9778

1 reference

6 August 2017

page(s)

1663-1672

1 reference

Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

How I use hydroxyurea to treat young patients with sickle cell anemia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Enalapril and hydroxyurea therapy for children with sickle nephropathy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Chemical and functional analysis of hydroxyurea oral solutions.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Prediction of adverse outcomes in children with sickle cell disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3133619

Pain in sickle cell disease. Rates and risk factors

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960355-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Cox's Regression Model for Counting Processes: A Large Sample Study

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960355-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Acquired DNA mutations associated with in vivo hydroxyurea exposure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21571150

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(11)60355-3

1 reference

6 August 2017

1 reference

6 August 2017

1 reference